← FDA Drug Approvals (Drugs@FDA)

OPTIVAR

NDA · New Drug Application · Sponsor: RISING · Approved 2000-05-22

Drug application

FDA Application #

NDA021127

Application type

New Drug Application

Brand name

OPTIVAR

Generic name

Azelastine Hydrochloride

Active ingredients

AZELASTINE HYDROCHLORIDE

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

Marketing status

Discontinued

Sponsor

RISING

First approval

2000-05-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown